Skip to Content

IP 254 (Ranitidine Hydrochloride 300 mg)

Pill with imprint IP 254 is Yellow, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Amneal Pharmaceuticals.

Ranitidine is used in the treatment of duodenal ulcer; gerd; cutaneous mastocytosis; erosive esophagitis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IP 254

Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254 Front
Ranitidine hydrochloride 300 mg IP 254 Back
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254

Ranitidine Hydrochloride

Imprint
IP 254
Strength
300 mg
Color
Yellow
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals

Labelers / Repackagers

NDC Code Labeler / Repackager
53746-0254 Amneal Pharmaceuticals LLC
65162-0254 Amneal Pharmaceuticals LLC
42291-0725 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.